An Electrochemical Strategy for Chalcogenation of <i>closo</i> -Dodecaborate (B <sub>12</sub> H <sub>12</sub> ) <sup>2–</sup> Anion

Advancements in thermal neutron generation technologies within clinical environments have led to a renewed interest in developing boron-containing compounds for boron neutron capture therapy (BNCT). Previous syntheses of several key boron cluster-based therapeutics with clinical relevance are low-yielding and have complicated workup procedures. Using electrolytic methods, we report the <i>in situ</i> oxidation of pseudohalides, [SCN]<sup>-</sup> and [SeCN]<sup>-</sup>, to synthesize pseudohalogenated products, B<sub>12</sub>H<sub>11</sub>YCN<sup>2-</sup> (Y = S or Se). Further, these compounds can be reduced to their respective thiol or selenol, [B<sub>12</sub>H<sub>11</sub>SH]<sup>2-</sup> (BSH) or [B<sub>12</sub>H<sub>11</sub>SeH]<sup>2-</sup> (BSeH), which are exceedingly nucleophilic and able to form zwitterionic sulfonium and selenonium compounds using alkyl-based electrophiles. The newly reported preparation of BSH and BSeH provides an efficient and convenient route to the preparation of key chalcogenated boron cluster building blocks for the biomedical and materials science communities.

Authors

Institutions

Publication Details

Journal
Inorganic Chemistry
Published
2025-04-24
DOI
https://doi.org/10.1021/acs.inorgchem.5c00469
Citations
1
Primary Topic
Boron Compounds in Chemistry
Type
article
Field-Weighted Citation Impact
1.36

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An Electrochemical Strategy for Chalcogenation of closo -Dodecaborate (B 12 H 12 ) 2– Anion

Nicholas A. Bernier, Tyler A. Kerr, Yessica Nelson, Alexander M. Spokoyny
1 citations
Inorganic Chemistry
Boron Compounds in Chemistry
1.36
article

An Electrochemical Strategy for Chalcogenation of closo -Dodecaborate (B 12 H 12 ) 2– Anion

Nicholas A. Bernier, Tyler A. Kerr, Yessica Nelson, Alexander M. Spokoyny
article en
1 citations

Abstract

Advancements in thermal neutron generation technologies within clinical environments have led to a renewed interest in developing boron-containing compounds for boron neutron capture therapy (BNCT). Previous syntheses of several key boron cluster-based therapeutics with clinical relevance are low-yielding and have complicated workup procedures. Using electrolytic methods, we report the <i>in situ</i> oxidation of pseudohalides, [SCN]<sup>-</sup> and [SeCN]<sup>-</sup>, to synthesize pseudohalogenated products, B<sub>12</sub>H<sub>11</sub>YCN<sup>2-</sup> (Y = S or Se). Further, these compounds can be reduced to their respective thiol or selenol, [B<sub>12</sub>H<sub>11</sub>SH]<sup>2-</sup> (BSH) or [B<sub>12</sub>H<sub>11</sub>SeH]<sup>2-</sup> (BSeH), which are exceedingly nucleophilic and able to form zwitterionic sulfonium and selenonium compounds using alkyl-based electrophiles. The newly reported preparation of BSH and BSeH provides an efficient and convenient route to the preparation of key chalcogenated boron cluster building blocks for the biomedical and materials science communities.

Inorganic ChemistryVol. 64(18)
California NanoSystems Institute (US), University of California, Los Angeles (US)
Camille and Henry Dreyfus Foundation, National Institute of General Medical Sciences, Division of Graduate Education
Openalex Percentile: Top 21%
Boron Compounds in Chemistry
1.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.